Non-export bans, green lines and solidarity between EU countries guarantee access to medicines 82 alerts were submitted from March 13 to April 27, 2020 by patients on the online platform for medicines’ lack and shortages. With them, the total number has increased to 922 since the system started functioning, announced the Bulgarian Association for Medicines …
Suspended imports are the cause of the lack of a cure for breast cancer with the active ingredient tamoxifen 10 mg. The first signal on the BAMPTD platform was received on 12 February 2020 by a journalist.
(български) За разлика от продажбите на лекарства, които през 2018 г. отбелязаха един от най-ниските си ръстове през последното десетилетие – около 5%, продажбите на медикаменти без рецепта, хранителни добавки и козметика продължават да бележат двуцифрени ръстове.
The first platform for drug shortage signaling in Bulgaria was presented by Boryana Marinkova, Executive Director of the Bulgarian Association for Medicines Parallel Trade Development (BAMPTD) at the Capital of Health Forum 2019 Almanac of Innovations in the Healthcare Forum held today.
(български) Сред факторите за недостиг на лекарства у нас, е че България е малък инеатрактивен пазар за внос на лекарства от големите компании. Лекарствата често стават обект на дерегистрация и напускат страната ни. Това разказа пред Радио София Боряна Маринкова – изпълнителен директор на Българската асоциация за развитие на паралелната търговия с лекарства.
We believe that by adopting our proposals, these cases can be resolved effectively and with complete safety for patients, as well as not requiring Bulgarian citizens to travel to neighboring and faraway countries in order to obtain treatment with deregistered from the country drugs due only to marketing reasons.
Bulgarian Association for Medicines Parallel Development of Drug Trade received two nominations for the annual awards of the Federation of Bulgaria Patient Forum “Daniela Seizova – In the Name of Life” 2019.
Business in Support of a Cause and a Best Patient-Corresponding Institution are the two categories in which BAMPTD is to be considered for a prize winner by Federation Bulgarian Patient Forum organization
BAMPTD online platform won the first prize in the Patient Project category in the second edition of the Healthcare Innovation and Good Practices competition, organized by Capital Weekly and the biopharmaceutical company Abbvie.
Parallel import is a possible solution for providing patients in case of shortage or absence of medicines. The most common reasons for drug shorages are marketing, manufacturing problems and dropping out of the manufacturer’s nomenclature, BDA reports.